Home > News > Starpharma: A “Nano” Star on the Rise
March 17th, 2005
Starpharma: A “Nano” Star on the Rise
Abstract:
On Monday, Starpharma—an Australian-based biopharmaceutical company focused on the development and application of dendrimer-based nanotechnologies—announced it was launching a new company, Dimerix Bioscience, to develop technology for the new field of receptor coupling. The overall size of the deal is pretty small—about AUD$200,000—and Starpharma will only have a 30% equity stake in the company, but it is yet another indication of Starpharma’s growing sophistication in leveraging its impressive intellectual property position in the area of dendrimer-based nanotechnologies.
Source:
NanoNovus
Bookmark:
Investments/IPO's/Splits
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013
Nanomedicine
Nano-needles for cells May 25th, 2013
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
Profiles
Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011
Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011
Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010
Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010